Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Roffi

Showing results (31-40 of 38) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 38 results.
Journal of Viral Hepatitis|December 22, 1999
Prediction of relapse or sustained response in biochemical responders by serum hepatitis C virus RNA monitoring during interferon therapyG Colloredo, L Roffi, M R Brunetto, et al.
Hepatology (Baltimore, Md.)|November 15, 1997
Evidence of functional and structural cardiac abnormalities in cirrhotic patients with and without ascitesM Pozzi, S Carugo, G Boari, et al.
European Journal of Gastroenterology & Hepatology|November 24, 1999
Antioxidant drugs combined with alpha-interferon in chronic hepatitis C not responsive to alpha-interferon alone: a randomized, multicentre studyG Idéo, A Bellobuono, S Tempini, et al.
Journal of Viral Hepatitis|April 12, 2000
Hepatitis C virus genotypes in a non-cirrhotic Italian population with chronic hepatitis C: correlation with clinical, virological and histological parameters. Results of a prospective multicentre studyG Saracco, R Sostegni, V Ghisetti, et al.
European Journal of Gastroenterology & Hepatology|March 15, 2001
Treatment with interferon-alpha2b of naive non-cirrhotic patients with chronic hepatitis C according to viraemia and genotype. Results of a randomized multicentre study. The North West Italian Hepatological GroupG Saracco, A Ciancio, V Ghisetti, et al.
Hepatology (Baltimore, Md.)|June 30, 2001
A randomized 4-arm multicenter study of interferon alfa-2b plus ribavirin in the treatment of patients with chronic hepatitis C not responding to interferon aloneG Saracco, A Ciancio, A Olivero, et al.
European Journal of Gastroenterology & Hepatology|June 9, 2001
Outcome of liver disease in a large cohort of histologically proven chronic hepatitis C: influence of HCV genotypeL Roffi, A Redaelli, G Colloredo, et al.
Journal of Hepatology|December 2, 1998
HCV genotypes in Northern Italy: a survey of 1368 histologically proven chronic hepatitis C patientsL Roffi, A Ricci, C Ogliari, et al.
Pageof 4

Showing results (31-40 of 38) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 38 results.
Journal of Viral Hepatitis|December 22, 1999
Prediction of relapse or sustained response in biochemical responders by serum hepatitis C virus RNA monitoring during interferon therapyG Colloredo, L Roffi, M R Brunetto, et al.
Hepatology (Baltimore, Md.)|November 15, 1997
Evidence of functional and structural cardiac abnormalities in cirrhotic patients with and without ascitesM Pozzi, S Carugo, G Boari, et al.
European Journal of Gastroenterology & Hepatology|November 24, 1999
Antioxidant drugs combined with alpha-interferon in chronic hepatitis C not responsive to alpha-interferon alone: a randomized, multicentre studyG Idéo, A Bellobuono, S Tempini, et al.
Journal of Viral Hepatitis|April 12, 2000
Hepatitis C virus genotypes in a non-cirrhotic Italian population with chronic hepatitis C: correlation with clinical, virological and histological parameters. Results of a prospective multicentre studyG Saracco, R Sostegni, V Ghisetti, et al.
European Journal of Gastroenterology & Hepatology|March 15, 2001
Treatment with interferon-alpha2b of naive non-cirrhotic patients with chronic hepatitis C according to viraemia and genotype. Results of a randomized multicentre study. The North West Italian Hepatological GroupG Saracco, A Ciancio, V Ghisetti, et al.
Hepatology (Baltimore, Md.)|June 30, 2001
A randomized 4-arm multicenter study of interferon alfa-2b plus ribavirin in the treatment of patients with chronic hepatitis C not responding to interferon aloneG Saracco, A Ciancio, A Olivero, et al.
European Journal of Gastroenterology & Hepatology|June 9, 2001
Outcome of liver disease in a large cohort of histologically proven chronic hepatitis C: influence of HCV genotypeL Roffi, A Redaelli, G Colloredo, et al.
Journal of Hepatology|December 2, 1998
HCV genotypes in Northern Italy: a survey of 1368 histologically proven chronic hepatitis C patientsL Roffi, A Ricci, C Ogliari, et al.
Pageof 4